The Associated Press on MSN4d
When's the Best Time to Get Your Flu and COVID Shots?Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters -- they're not just another dose of ...
The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines ... A third player in the market, Novavax, filed for approval of a non-mRNA vaccine ...
A second group of adults aged 50 to 64 received mRNA-1083 or GSK’s influenza vaccine Fluarix, once again given alongside Spikevax ... on mRNA – and Sanofi/Novavax, which are working on ...
On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health and Social Care, signed a Termination and Settlement Agreement ...
Inovio Pharmaceuticals Inc. 0.36% $143.32M ...
The company exceeded expectations with its Spikevax revenue, notably due to an earlier approval that allowed for a rapid uptake in retail channels. This success drove Moderna’s Q3 sales to $1.8 ...
The Massachusetts-based company said that third-quarter revenue from its Spikevax shot came in at $1.8 billion, with $1.2 billion of the sales coming in the United States. The overall figure ...
A trial participant developed amytrophic lateral sclerosis (ALS), an event deemed unrelated to vaccination. Novavax’s shares jumped in pre-market trading on the news but settled once markets opened.
Analysts had expected a loss of US$753 million, or US$1.90 a share, according to LSEG data. Its Spikevax Covid vaccine brought in sales of US$1.8 billion, up 3.5 per cent over the previous year and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback